Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:48 PM
Ignite Modification Date:
2025-12-24 @ 3:48 PM
NCT ID:
NCT04742192
Eligibility Criteria:
Inclusion Criteria:
* Adult male or female patients ≥18 years old or 'adults' according to age of majority as defined by the local regulations
* Patient or next of kin/legal representative is willing and able to provide informed consent according to the local regulations, where applicable
* Patients with stage IA to IIIB (on the basis of pathologic criteria) NSCLC with adenocarcinoma, or mixed histology with an adenocarcinoma component who have undergone surgical resection of the tumour during the preceding 6 weeks
* Availability of FFPE tissue specimen suitable for EGFRm testing (either the primary diagnostic sample or the surgically resected tumour specimen)
* Availability of medical records at the participating site detailing the initial diagnosis, staging, and surgical management of NSCLC
Exclusion Criteria:
Patients who fulfil any of the following exclusion criteria will not be eligible for the study:
1. Histology of the tumour is considered not to be of primary lung in origin
2. Histology is pure squamous cell carcinoma, pure small cell carcinoma, or large cell carcinoma origin lacking any immunohistochemistry evidence of adenocarcinoma differentiation -
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04742192
Study Brief:
Protocol Section:
NCT04742192